MI Skin Innovations

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials
• Hidradenitis suppurativa1 trial
• Obesity1 trial
• Psoriasis1 trial

Phase

• Phase 22 trials
• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting3 trials
• Completed1 trial

Lead sponsor

• Bluefin Biomedicine, Inc.2 trials
• Eli Lilly and Company1 trial
• Pfizer1 trial

Running trials

• Active, not recruiting

  A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

  NCT07287644· Phase 2/3· Bluefin Biomedicine, Inc.· Source

• Active, not recruiting

  A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

  NCT07105488· Phase 2· Bluefin Biomedicine, Inc.· Source

• Active, not recruiting

  A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

  NCT05995964· Phase 2· Pfizer· Source

Closed trials

• Completed

  Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

  NCT06588283· Phase 3· Eli Lilly and Company· Source